Search results

  • NeurAxon, Inc.
    NeurAxon, Inc.
    781.356.1603
    639 Granite St, 02184  Braintree

    Since its inception in 2004, NeurAxon has been dedicated to developing novel pain therapeutics targeting neuronal nitric oxide synthase (nNOS). The Company has issued and pending composition of matter patents on selective small molecule inhibitors of nNOS.